Skip to content
Studies have shown that active fund managers routinely underperform the S&P500 index*
Home
Articles
WALL STREET X
Forecasts
Portfolios
Wall Street X
Articles
Forecasts
Portfolios
Search
Results for
{phrase}
(
{results_count}
of
{results_count_total}
)
Displaying
{results_count}
results of
{results_count_total}
HCW Biologics Inc. (NASDAQ: HCWB)
HCWB Stock Predictions and Ratings
WSX Rating:
SELL
WSX Forecast (1yr):
-5.20%
Analyst Rating:
STRONG BUY
Analyst Forecast (1yr):
48.80%
HCWB Stock Analysis
HCWB
PE Ratio:
HCWB
PEG Ratio:
Not Available
HCWB
Forward EPS Growth (12 month):
0.00%
HCWB
PS Ratio:
0.5
HCWB
PSG Ratio:
Not Available
HCWB
Forward Revenue Growth (12 month):
0.00%
HCWB Articles
No data was found